Key facts
- This page summarizes Mark Gustafson's Form 4 filing for Alzamend Neuro, Inc. (ALZN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Apr 2022, 17:00.
Mark Gustafson - 31 Mar 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)
- Reporting relationship
- Director
- Issuer ticker
- ALZN
- Reported as of
- 31 Mar 2022
- Net transaction value
- -$24,202
- SEC form
- 4
- Accepted by SEC
- 04 Apr 2022, 17:00:20 UTC
- Prior SEC filing
- 15 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Gustafson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Gustafson filed Form 4 for Alzamend Neuro, Inc. (ALZN) on 04 Apr 2022.
Change
- Previous filing in this sequence was filed on 15 Mar 2022.
- Current net transaction value: -$24,202.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALZN
transaction
Common Stock
Sale
- Transaction value
- $24,202
- Shares
- -20,000
- Change %
- -25%
- Price
- $1.21
- Shares after
- 60,000
- Date
- 31 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.